Evaluation of Medical and Nursing Management for Bronchiectasis
1 other identifier
observational
65
0 countries
N/A
Brief Summary
The purpose of this research is to retrospectively evaluate current clinical care of Bronchiectasis (non-cystic fibrosis \[CF\]) in adults from a multidisciplinary management perspective. This evaluation aims to address the important gaps in current clinical care in 2011, 2013 and July 2016- Jun2017. The primary outcome of this evaluation is to compare the efficacy of current multidisciplinary clinical practice to the British Thoracic Society (BTS) \& Thoracic Society of Australia and New Zealand (TSANZ) guidelines for bronchiectasis. Secondary outcomes of this evaluation will determine the impact of clinical care in 2011, 2013 and July2016-June2017 through quantification of:hospital utilization for using hospital admission data, average length of stay, readmission rates within 28 days, emergency service attendance, outpatient review, exacerbations use of antibiotics, use of Hospital and Home (H@H), number of contacts with the respiratory nursing service and type of contacts with the respiratory nursing service.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2015
CompletedFirst Submitted
Initial submission to the registry
April 6, 2017
CompletedFirst Posted
Study publicly available on registry
June 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2023
CompletedMarch 29, 2023
March 1, 2023
7.8 years
April 6, 2017
March 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients with bronchiectasis guideline compliant care
Percentage of patients who meet guideline compliant care for management of bronchiectasis based in TSANZ and BTS guideline recommendations for outpatient management
12 months
Secondary Outcomes (4)
Number of admissions
12 months
Impact of bronchiectasis outpatient management on patient outcomes
12 months
Number of outpatient (OPD) attendances
12 months
Patient mortality
0 years up to 4 to 7 years dependent on qualifying year
Study Arms (3)
2011 Patients
Evaluation of multidisciplinary management of bronchiectasis compared to the British Thoracic Society Guidelines 2010.
2013 Patients
Evaluation of multidisciplinary management of bronchiectasis compared to the British Thoracic Society Guidelines 2010. Comparison of 2011, 2013 cohorts \& July16/June17.
July2016/Jun17 Patients
Evaluation of multidisciplinary management of bronchiectasis compared to the British Thoracic Society Guidelines 2010 \& 2014. Comparison of 2011, 2013 cohorts \& July16/June17.
Eligibility Criteria
Patients admitted or attending Emergency Department at The Queen Elizabeth Hospital in 2011, 2013 and July2016-June2017 with primary or secondary diagnosis of bronchiectasis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Antony Veale, PhD
The Queen Elizabeth Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
April 6, 2017
First Posted
June 8, 2018
Study Start
June 22, 2015
Primary Completion
March 28, 2023
Study Completion
March 28, 2023
Last Updated
March 29, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
Available upon request